Back

Aged-black garlic (Abg10+) supplementation effect in blood lipoprotein profile in Grade I Hypertensive subjects. A randomized, triple-blind controlled trial.

Serrano, J. C.; Castro-Boque, E.; Garcia Carrasco, A.; Moran Valero, M. I.; Diez Municio, M.; Bermudez Lopez, M.; Valdivielso, J. M.; Espinel, A. E.; Portero-Otin, M.

2026-04-30 nutrition
10.64898/2026.04.20.26351262 medRxiv
Show abstract

Aged black garlic (ABG) is rich in organosulfur compounds such as Sallylcysteine (SAC) and may influence lipid metabolism, although evidence from controlled trials remains limited. The aim of this study was to evaluate the impact of a low-dose SAC-optimized ABG on blood lipid profiles in Grade I hypertensive individuals. A randomized, triple-blind, placebo-controlled trial was conducted with 75 Grade I hypertensive participants receiving either 250 mg of ABG or a placebo daily for 12 weeks. Plasma lipoproteins and subclass composition were quantified by NMR spectroscopy, and metabolic clusters were explored using kmeans and PLSDA. ABG supplementation led to a significant reduction in the total number of particles and HDL particles. Detailed analysis of XXL-VLDL particles showed a significant decrease in the percentage of both free and esterified cholesterol, alongside an increase in triglyceride percentage. Conversely, large HDL particles exhibited a beneficial remodeling characterized by an increase in phospholipid content and a decrease in triglyceride percentage. Furthermore, cluster analysis demonstrated that participants with a more adverse baseline metabolic profile experienced a significant reduction in total triglycerides and VLDL-lipid content after ABG intake. These results suggest that low-dose ABG supplementation induces specific qualitative improvements in lipoprotein subclasses, particularly enhancing HDL functionality markers and reducing the cholesterol load in large VLDL particles, which may provide cardiovascular benefits in hypertensive individuals with metabolic impairment

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Food & Function
12 papers in training set
Top 0.1%
33.7%
2
PLOS ONE
4510 papers in training set
Top 17%
10.3%
3
Scientific Reports
3102 papers in training set
Top 7%
9.4%
50% of probability mass above
4
Frontiers in Nutrition
23 papers in training set
Top 0.2%
6.5%
5
Current Developments in Nutrition
15 papers in training set
Top 0.2%
5.0%
6
Journal of Translational Medicine
46 papers in training set
Top 0.3%
3.1%
7
Nutrients
64 papers in training set
Top 0.8%
2.1%
8
Atherosclerosis
29 papers in training set
Top 0.6%
2.1%
9
The Journal of Nutritional Biochemistry
13 papers in training set
Top 0.1%
1.9%
10
eLife
5422 papers in training set
Top 39%
1.8%
11
Food Chemistry
12 papers in training set
Top 0.2%
1.5%
12
BioMed Research International
25 papers in training set
Top 2%
1.5%
13
BMJ Nutrition, Prevention & Health
10 papers in training set
Top 0.3%
1.1%
14
iScience
1063 papers in training set
Top 24%
1.0%
15
Redox Biology
64 papers in training set
Top 0.6%
1.0%
16
Translational Psychiatry
219 papers in training set
Top 4%
0.9%
17
Antioxidants
25 papers in training set
Top 0.5%
0.8%
18
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.8%
19
Frontiers in Endocrinology
53 papers in training set
Top 2%
0.7%
20
International Journal of Molecular Sciences
453 papers in training set
Top 17%
0.7%
21
Journal of the American Heart Association
119 papers in training set
Top 4%
0.5%
22
European Journal of Pharmacology
11 papers in training set
Top 0.6%
0.5%
23
Cell Discovery
54 papers in training set
Top 6%
0.5%
24
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 3%
0.5%